Circana sees modest gains in 2024 back-to-school tech sales
Wearables and tablets lead growth as overall revenue increases 1%, with value-driven spending shaping back-to-school sales trends
Wearables and tablets lead growth as overall revenue increases 1%, with value-driven spending shaping back-to-school sales trends
CVS Health/Morning Consult survey reveals most pharmacy teams and consumers say more care and services can and should be provided in community pharmacy.
Retailer prepares for National Prescription Drug Take Back Day on Saturday, Oct. 26.
2025 ratings feature enhanced methodology, evaluating 30+ quality measures.
Community pharmacy group urges both candidates to back PBM reform.
The immersive event centered on topics including artificial intelligence, organized retail crime, reimbursement reform, real estate trends, retail media networks, innovation in retail and the state of wellness in the United States.
Pharmaceutical distributor sales reached $758 billion amid some of the lowest profit margins in the study’s 95-year history — 0.3 percent (net after taxes) and 1.7 percent (gross) in 2023.
Nearly half of women ages 40-60 lose two hours of sleep a night due to spiraling thoughts.
Amid higher prices, consumers prioritize experiences and value to celebrate the season.
Lower prices on drugs patients can’t find won’t be much help, says NCPA.
Walgreens Boots Alliance announced the closings as part of its earnings report for the fourth quarter of fiscal 2024, which ended August 31. The company posted sales and profits that beat Wall Street's expectations.
To educate others on its many benefits, the personal care brand has teamed up with board-certified physician and esteemed wellness expert, Dr. Poonam Desai.
Despite this gap, women pharmacy leaders are making a significant impact in their communities by adding differentiated, patient-centric services, empowering female patients to be more engaged in their care and offering support and guidance to their colleagues.
Company also plans to either close or sell 29 related regional pharmacies in the coming months.
Perceptions around private brands have changed; they are no longer seen merely as generics or national brand equivalents, Doug Baker, vice president, industry relations at FMI, said in releasing the report, titled “The Power of Private Brands 2024.”